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Abstract 
We observed that lipopolysaccharide (LPS, 1 pg/ml) can suppress [3H]thymidine incorporation into acid-insoluble fraction in a 
mouse macrophage cell line J774 (over 70% at 6 h) without affecting the uptake of [3H]thymidine or DNA polymerase activity. 
Paralleling this suppression, a decrease in the thymidine kinase (TKJ activity, but not of thymidine monophosphate (TMP) kinase and 
thymidine diphosphate (TDP) kinase, was observed. LPS dose-dependently increased intracellular CAMP levels to about 3.5times basal 
at 6 h, proportionally to the decrease of the TK activity. Elevation of intracellular CAMP by several reagents also decreased TK activity. 
Apparently LPS treatment elevates CAMP concentration by decreasing the low K, CAMP phosphodiesterase activity (58% at 6 h). The 
time course of CAMP-deperrdent protein kinase (PK-A) activity during the first 6 h after LPS treatment correlated with that of CAMP 
concentration. Treatment wi1.h a PK-A inhibitor restored about 63% of LPS-induced reduction of TK activity at 6 h. At longer times, 
however, there was a discrepancy between the change of CAMP concentration or PK-A activity and the reduction of TK activity. 
Therefore, protein kinase activation caused by the accumulation of intracellular CAMP probably triggers some mechanism responsible for 
the reduction of the TK activity. 
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1. Introduction 
Macrophages play an important role in host defense 
against bacterial infection and are the major cellular targets 
for bacterial lipopolysaccharide (LPS). It is known that 
LPS stimulates macrophages to secrete immunoregulatory 
substances, including colony stimulating factor, inter- 
let&in-l, tumor necrosis factor and arachidonic acid 
metabolites, and also enhances their bactericidal activity 
[l-5]. 
Previously, we have reported that oil-induced guinea-pig 
peritoneal exudate macrophages incorporate [ 3H]thymidine 
into acid-insoluble fraction. The incorporated [ 3H]thymi- 
dine was detected in short fragments of DNA corre- 
* Corresponding author. Fax: +81 853 229304. 
sponded to the Okazaki fragments, and LPS treatment 
suppressed the formation of these fragments [6-91. 
It has also been reported that f3H]thymidine incorpora- 
tion is suppressed by dibutyryl CAMP and PGE,, which 
are known to elevate intracellular cyclic AMP (CAMP) 
concentration, in guinea-pig peritoneal exudate 
macrophages [6] and in murine bone marrow-derived 
macrophages [lo]. However, so far little has been eluci- 
dated regarding the intracellular molecular mechanisms of 
suppression of [ 3H]thymidine incorporation by these 
agents. 
Most recently, we have observed that the level of 
L3H]thymidine incorporation was markedly reduced in the 
5774-l murine macrophage-like cell line and in peritoneal 
exudate macrophages treated with LPS. Therefore, we 
tried to determine whether the observed suppression of 
[3Hlthymidine incorporation after LPS treatment is depen- 
dent on the accumulation of intracellular CAMP. 
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Our findings suggest that during the first 6 h after LPS 
treatment of 5774 cells there is a decrease in the low K, 
phosphodiesterase activity, accumulation of CAMP and 
activation of CAMP-dependent protein kinase (PK-A). The 
activated PK-A may play an important role on the ob- 
served reduction of thymidine kinase (TK) activity. 
2. Materials and methods 
2.1. Reagents 
[Methyl-3H]thymidine (60 Ci/mmol) and [3H]3’,5’- 
cyclic AMP (30 Ci/mmol) were obtained from ICN 
Biomedicals and New England Nuclear, respectively. LPS 
(E. coli 0127:B8, Westphal Type) was purchased from 
Difco Laboratories. Isoproterenol, theophylline, papaver- 
ine, cholera toxin, 3-isobutyl-1-methylxanthine (IBMX), 
indomethacin, ionomycin, 12-o-tetradecanoyl phorbol 13- 
acetate (TPA) and snake venom were obtained from Sigma 
Chemical Co. Islet-activating protein (pertussis toxin) were 
obtained from Funakoshi Co. 1-(5-Isoquinolinesulfonyl)- 
2-methylpiperazine dihydrochloride (H-71, 1-[N,O- 
bis(l,5-isoquinolinesulfonyl-L-tyrosyl]-4-phenylpiper~ine 
(KN-621, N-[2-( p-bromocinnamylamino)ethyl]-5-iso- 
quinolinesuifonamide (H-89) and N-(Zaminoethyl)-5- 
chloro-isoquinoline-&sulfonamide (CKI-7) were obtained 
from Seikagaku Co. All other reagents were purchased 
from Miyata Chemical Co., Shimane, and were used with- 
out further purification. 
2.2. Cell culture 
The murine macrophage cell line 5774.1 (herein re- 
ferred to as 5774) was obtained from the RCB Cell Bank. 
Cells were grown in RPM1 1640 medium containing 100 
U/ml of penicillin G potassium, 100 pg/ml of strepto- 
mycin sulfate, 4 mM L-glutamine and 10% FBS at 37°C 
under 5% CO, in humidified air. 
2.3. L3H]Thymidine incorporation assay 
5774 cell monolayers prepared in tissue culture plates 
(1 * lo6 cells/2 ml) were pretreated for 1 h with or 
without protein kinase inhibitors, and incubated with LPS 
and indicated reagents for further 6 h at 37°C. Then, 0.5 
&i of [3H]thymidine was added and the cultures were 
incubated for an additional 30 min. Culture medium was 
removed and 2 ml of 1 N NaOH were added to each well. 
Two h later the content of each well was put into a test 
tube and 1 ml of 2 N HCl was added to each tube followed 
by 10 ml 10% trichloroacetic acid (TCA). The TCA-in- 
soluble fraction was collected on a glass fiber filter and the 
radioactivity was measured in a Packard scintillation 
counter. 
2.4. Total cellular incorporation of L3H]thymidine 
Incorporated radioactivity was determined as described 
by Aronow et al. [ll]. Briefly, cells (1 . lo6 cells) were 
incubated in the presence or absence of 1 mg/ml LPS for 
6 h. Following the incubation, 0.5 &i of [3H]thymidine 
was added to each well and incubated for a further 5 min. 
After washing twice with cold PBS, the cells were ex- 
tracted with 1.5 ml of 0.5 N perchloric acid (PCA) for 30 
min on ice. The supematants obtained by centrifugation at 
3000 X g for 15 min and the PCA-insoluble fraction were 
disolved in 1 ml of tissue solubilizer (NCS, Amersham) 
after washing with 95% ethanol, and then the radioactivity 
was measured in a Packard scintillation counter. The total 
counts (PCA-soluble and -insoluble fractions) were deter- 
mined. 
2.5. Thymidine kinase assay 
Harvested cells (1 * lo6 cells) were washed twice with 
cold PBS and resuspended in 1 ml of medium A contain- 
ing 50 mM Tris-Cl- (pH 7.51, 10 mM dithiothreitol 
(DTT), 2 mM phenyhnethylsulfonyl fluoride and 0.1% 
Triton X-100. The cells were disrupted by sonication, and 
the supematant obtained by centrifugation at 214000 X g 
for 1 h at 4°C was dialyzed three times for 12 h at 4°C 
against 500 ml of extraction buffer. The dialyzed extract 
was used as an enzyme for TK assay. TK activity was 
determined by a modification of the method of Johnson et 
al. [12]. An aliquot of 20 ml of the enzyme preparation 
was added to 60 ml of a reaction mixture containing (final 
concentration) 50 mM Tris-Cl- (pH 8.01, 15 mM NaF, 3.6 
mM 2-mercaptoethanol, 5 mM ATP, 2.5 mM MgCl,, 50 
PM thymidine including 0.5 PCi of [3H]thymidine. After 
incubation for 30 min at 37°C the reaction was terminated 
by chilling to 0°C. Samples of 50 ~1 were spotted on a 
Whatmann DE81-cellulose paper (15 mm X 15 mm). The 
paper was washed three times with 1 mM ammonium 
formate and twice with 95% ethanol, and dried. The 
amount of radioactivity was determined with a liquid 
scintillation counter. One unit of enzyme activity was 
defined as the amount of products in nmol/mg protein per 
hour. 
2.6. Cyclic AMP assay 
After incubation, the cells (1 * 106/ml) were immedi- 
ately washed with cold phosphate-buffered saline (PBS), 
the pellet was resuspended in 0.1 N HCl and disrupted 
with 30 strokes in a Dounce homogenizer in an ice bath. 
The nuclei and cell debris were removed by centrifugation 
at 10000 X g for 5 min at 4°C. The CAMP contents were 
determined by the protein binding assay (Yamasa CAMP 
kits). 
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2.7. Cyclic AMP phosphodiesterase assay 
Cells (1 - 106/ml) were washed three times with cold 
PBS, resuspended in 1 ml of medium B containing 5 mM 
Tris-Cl- buffer (pH S.O>, 0.25 M sucrose, 3 mM CaCl,, 
and 1 mM EDTA and Idisrupted with 30 strokes in a 
Dounce homogenizer in an ice bath. The nuclei and cell 
debris were removed by centrifugation at 214000 X g for 
1 h at 4°C. Phosphodiesterase activity of the cytosol 
fraction was measured using the method described by 
Thompson and Appleman [13]. The first stage reaction 
mixture of 0.5 ml contained 50 mM Tris-Cl- buffer (pH 
S.O>, 10 mM MgCl,, 0.5% bovine serum albumin, 
[3H]3’,5’-cAMP and cytosol fraction equivalent to 50 pg 
protein. Phospodiesterase activity was measured at a sub- 
strate concentration of 0.5 /.LM CAMP to assess low K, 
activity and at 1 mM to assess high K, activity. After 
incubation for 15 min at 37°C the reaction mixture was 
transferred to a boiling water bath for 2 min to terminate 
the reaction. The reaction mixture was then incubated with 
50 pg of snake venom for 30 min at 37°C. The reaction 
was stopped by the additions of 0.8 ml 1:l slurry Bio-Rad 
resin, AG 1 X 2 (200 :< 400 mesh). The amount of 
[ 3H]adenosine left in the supematant after centrifugation 
was measured by means of a liquid scintillation spectrome- 
ter. One unit of enzyme activity was defined as the amount 
cleaving 1 nmol of CAMP per hour. Protein was deter- 
mined by the method of Lowry et al. [14]. 
2.8. PK-A assay 
Cell extract supematants were prepared as above for the 
phosphodiesterase assay and PK-A activity was measured 
using a modification of the method of Reimann and Be- 
ham [15]. The reaction mixture of 0.1 ml contained 20 mM 
Tris-Cl- buffer (pH 7.51, 5 mM magnesium acetate, 5 mM 
IBMX, 30 PM [y-3’ PIATP and 100 pg whole histone. 
The reactions were initiated by adding cytosol fraction 
equivalent to 50 pg protein from control or LPS-treated 
cells to the reaction mixture with or without 10 PM H-89, 
which is a potent and selective PK-A inhibitor [16], incu- 
bated for 10 min at 30°C and then 3 ml cold 10% TCA 
was added to each tube. The acid-insoluble fraction was 
collected on a glass fiber filter and the radioactivity was 
measured in a scintillation counter. PK-A activity observed 
for LPS-treated cells was 5% to 12% lower than full PK-A 
activity obtained by the addition of 1 PM CAMP in vitro 
assay system. 
3. Results 
3.1. Effect of LPS on [311]thymidine incorporation 
As shown in Fig. 1, addition of 1 pg/ml LPS to 5774 
cell cultures suppressed [ 3H]thymidine incorporation into 
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Fig. 1. Time course of [‘Hlthymidine incorporation (solid lines) and TK 
activity (broken lines) after LPS treatment. 5774 cell monolayers (1. lo6 
cells/ml) were cultured for indicated times with (0,O) without (0, W ) 
1 pg/ml LPS. [3H]Thymidine was added to the cell culture for 30 min 
before each measurement. TK assays were carried out as described under 
Section 2 with 30 to 50 pg of enzyme protein. As control experiments, 
the [ 3H]thymidine incorporation and TK activity per 1. lo6 cells without 
LPS (zero hour) were 92192*2301 dpm and 1.95 kO.10 unit, respec- 
tively. These values were settled as 100% and expressed as the mean& 
S.D. of triplicate cultures. 
acid-insoluble fraction by about 15% after 1 h and more 
than 70% after 6 h. LPS-induced suppression was dose-de- 
pendent; significant suppression was detected in doses 
greater than 0.1 ng/ml of LPS and maximum suppression 
occurred at a concentration of 1 pg/ml (data not shown). 
Possible main explanations for the LPS-induced sup- 
pression of [3H]thymidine incorporation include: (1) de- 
creased cell permeability; (2) decreased DNA polymerase 
activity; (3) increased amounts of thymidine triphosphate 
(TV); and (4) . h’b’t’ m I 1 ran of the conversion process from 
radioactive incorporated L3H]thymidine to TTP. When 
[3H]thymidine (0.5 &i) was added to J774 cells that had 
been exposed to 1 pg/ml LPS for 6 h, no significant 
suppression of total cellular incorporation was observed 
(24930 f 2077 and 28665 f 2888 dpm for control and 
LPS-treated cultures, respectively), suggesting that LPS 
does not affect cell permeability. The level of DNA poly- 
merase (Y and p activity remained unchanged after 6 h of 
LPS treatment of J774 cells, as previously reported for 
guinea-pig peritoneal exudate macrophages [9] (data not 
shown). Furthermore, there were no differences between 
the amounts of lTP in LPS-treated cells and control cells 
(data not shown). These results indicate that LPS may be 
affecting the conversion process from incorporated ra- 
dioactive thymidine to TIP as substrate for DNA synthe- 
sis. 
Therefore, we investigated the relationship between the 
suppression of [ 3H]thymidine incorporation into acid-in- 
soluble fraction and the level of TK, TMP kinase or TDP 
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Fig. 2. Change in intracellular CAMP concentration in 5774 cells follow- 
ing LPS treatment. 5774 cells (1. lo6 cells/ml) were cultured with (0) 
or without (0) 1 pg/ml LPS for indicated times. Intracellular CAMP 
concentration was measured as described in Section 2. The results are 
expressed as the mean percentage&S.D. of triplicate cultures. Cyclic 
AMP concentrations in the control cultures (zero time) without LPS were 
12.3 f 1.0 pmol per 1. lo6 cells and this value was settled as 100%. 
kinase activity in LPS-treated 5774 cells. Homogenates of 
cells cultured with or without LPS were centrifuged at 
214000 X g and aliquots of the supematant were em- 
ployed as enzyme [12,17,18]. As is clearly shown in Fig. 
1, marked reduction of TK activity following closely the 
suppression of [ 3H]thymidine incorporation occurs after 
LPS treatment. On the other hand, the activities of TMP 
and TDP kinases did not change after 24 h of LPS 
treatment (control and LPS-treated values were: for TMP, 
0.14 + 0.04 and 0.13 f 0.10 mmol/mg per h; for TDP: 
0.07 f 0.01 and 0.08 + 0.01 mmol/mg per h). 
3.2. Intracellular cyclic AMP accumulation by LPS 
Previously, we have reported that when guinea-pig peri- 
toneal exudate macrophages are cultured in medium con- 
taining dibutyryl CAMP or PGE,, a considerable reduction 
of [ 3H]thymidine incorporation into acid-insoluble fraction 
is observed [6]. Thus, we investigated whether the reduc- 
tion of TK activity in J774 cells by LPS treatment is 
related to accumulation of intracellular CAMP. As shown 
in Fig. 2, maximum intracellular CAMP accumulation 
(35times control level) was achieved at 6 h after addition 
of 1 pg/ml LPS (12.3 f 1.0 vs. 44.3 f 1.2 pmol per 
1 * lo6 cells) and declined to about 2.0-times the control 
level after 12 h. These results suggest that the reduction of 
TK activity by LPS treatment might be related to elevated 
intracellular CAMP concentrations. 
3.3. Correlation between intracellular CAMP concentra- 
tion and TK activity 
As can be seen in Fig. 3, at 6 h the accumulation of 
intracellular CAMP was dependent upon LPS concentra- 
tions (from 1 ng to 10 ,ug/ml), and the LPS-induced 
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Fig. 3. Effect of increasing concentration of LPS on intracellular CAMP 
concentration and TK activity. J774 cell monolayers (1.106 cells/ml) 
were cultured with the indicated doses of LPS (0.1 ng to 10 pg/ml) for 6 
h. The intracellular CAMP concentration was measured as described in 
Section 2. Cyclic AMP concentration per lo6 cells in control cell 
(without LPS) at 6 h was 11.9* 1.8 pmol. These values were settled as 
100% and expressed as the mean&SD. of triplicate cultures. Inset: cell 
monolayers (1. lo6 cells) were cultured with or without LPS (0.1 ng to 
10 pg/ml) for 6 h. The ordinate shows TK activity expressed as reduced 
percentage to control cell (without LPS) at 6 h and the abscissa shows 
CAMP concentration expressed as increased percentage to control at 6 h. 
TK activity obtained without LPS was 1.95 fO.10 unit (mean of triplicate 
cultures). 
reduction of TK activity was proportional to the accumula- 
tion of intracellular CAMP (Fig. 3, insert). Table 1 shows 
that a 3- to 4-fold elevation in the intracellular CAMP 
concentration can be observed with 1 pg/ml LPS, 1 mM 
theophylline, 0.1 mM papaverine, 1 pg/ml cholera toxin, 
5 PM PGE,, 0.5 mM isoproterenol and 0.1 mM IBMX. 
All these agents caused a significant decrease in TK 
activity, and this decrease was dose-dependent and propor- 
Table 1 
Effects of several materials on TK activity and CAMP concentration a 
Materials Dose TK activity b (%) CAMP concentration c (%) 
None - 100 100 
LPS 1 pg/ml 12 342 
Theophylline 1 mM 10 352 
Papaverine 1OOpM 15 356 
IBMX 1OO~M 21 356 
Cholera toxin 1 pg/ml 12 398 
Isoproterenol 500 PM. 25 396 
PGE, ~/AM 18 395 
a J774 cell monolayers (1. lo6 cells/ml) were cultured with or without 
the indicated agents for 6 h. TK activity and CAMP concentration were 
measured as described in Section 2. The results are expressed as the mean 
! 
ercentage of control in triplicate cultures. 
TK activity and ’ cAMP concentration per lo6 cells in the control 
culture were 1.95 *O.lO unit and 12.4f 0.8 pmol, respectively. 
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tional to the amount of intracellular CAMP (data not 
shown). 
It has been reported thalt LPS can activate protein kinase 
C (PK-C) [19,20] and that phorbol ester (a PK-C activator) 
can enhance adenylate cyclase activity in S49 lymphoma 
cells [21]. We investigated whether or not the activation of 
PK-C by LPS treatment can induce intracellular CAMP 
accumulation in J774 cells. The phorbol ester TPA (0.1 to 
100 nM) failed to elevate intracellular CAMP concentra- 
tions or to reduce TK ac:tivity over 24 h, indicating that 
PK-C does not participate in these events (data not shown). 
3.4. Effect of LPS on CAMP phosphodiesterase activities 
Intracellular CAMP concentration is dependent upon the 
activities of adenylate cyclase and CAMP phospho- 
diesterase. We examined adenylate cyclase activity in the 
membranes prepared from J774 cells treated with 1 pg/ml 
LPS for various times (up to 12 h) by the method of 
Salomon et al. [22]. No si,gnificant differences in adenylate 
cyclase activity between the membranes prepared from 
LPS-treated (18.5 pmol/‘min per mg protein) and non- 
treated (20.2 pmol/min per mg protein) cells were de- 
tected. Next we measured the CAMP phosphodiesterase 
activity in J774 cells treated in the same way (Table 2). 
The activity of the low K,,, CAMP phosphodiesterase was 
observed to be decreased lby 27% at 3 h and by 58% at 6 h 
of LPS treatment, while no changes in the activity of the 
high K, phosphodiesterase were detected. The activity 
gradually recovered to 80% of control level after 12 h. No 
differences in K, values for the low K, CAMP phospho- 
diesterase were observed between preparations from LPS- 
treated (K, = 0.32 PM) <and non-treated cells (K, = 0.36 
PM). Therefore, LPS-induced elevation of CAMP levels 
involves a reduction of the low K, CAMP phospho- 
diesterase activity. The mechanism of this reduction is still 
unknown. Addition of increasing concentrations of the 
214000 X g supematant prepared from LPS-treated cells 
could not reduce the CAMP phosphodiesterase activity, 
indicating that the supematant does not contain inhibitory 
factors, and LPS itself could not directly inhibit the activ- 
ity of partially purified CAMP phosphodiesterase (data not 
shown). 
Table 2 
Effect of LPS on CAMP phosphodiesterase in 5774 cells ’ 
Substances added to culture 
None 
LPS (1 k&n0 
cAMP phosphodiesterase activity (unit) 
lh 3h 
0.62 f 0.02 0.59 f 0.01 
0.59 * 0.02 0.43 f 0.03 
3.5. Participation of PK-A on TK activity 
Since many effects of CAMP can be mediated by PK-A 
[lo], we examined the effect of LPS treatment on the 
activity of this enzyme. The total protein kinase activity in 
the 214000 X g supematant from LPS-treated cells was 
more than 2-times higher than that from non-treated cells. 
When H-89 (10 PM), a potent and selective inhibitor of 
PK-A, was added to the reaction mixture, the total kinase 
activity was inhibited to very low levels (about 30% of 
controls) in both LPS-treated and non-treated cells (data 
not shown). These results indicate that the substantial 
increase in kinase activity was derived from PK-A. Maxi- 
mum activity of PK-A (3.1-times the control) was achieved 
at 6 h and then declined to 180% of control level at 12 h, a 
time course following closely that of decreased CAMP 
phosphodiesterase activity and increased intracellular 
CAMP concentration (Fig. 2 and Table 2). 
The possible involvement of PK-A in the reduction of 
TK activity was investigated by the use of protein kinase 
inhibitors. Pretreatment of 5774 with 1 PM H-89 for 1 h 
restored about 63% of LPS-induced suppression of TK 
activity. We also observed that TK activity was not sup- 
pressed when the partially purified enzyme was preincu- 
bated in the presence of purified PK-A and ATP, suggest- 
ing that phosphorylation of TK was not involved. More- 
over, there were no inhibitory factors in the supematant of 
LPS-treated cells. Fig. 4 shows that in cells treated for 12 
h, 1 PM H-89 restored only 23% of the suppression, 
indicating that PK-A may play an important role in the 
suppression of TK activity at early stages (up to 6 h) of 
LPS treatment. 
3.6. Effect of intracellular Ca2 ’ on TK activity 
It has been reported that LPS treatment enhances the 
hydrolysis of phosphatidylinositol 4,5_bisphosphate and 
elevates intracellular Ca *’ levels [19]. To assess whether 
increased intracellular Ca*+ concentrations can affect the 
TK activity, 5774 cells preloaded with the fluorescent 
calcium-sensitive probe fura- were treated with iono- 
mycin (0.1 to 50 PM) and monitored [23]. Ionomycin 
induced a rapid ( < 10 SC) and transient ( u 3 min) rise in 
intracellular Ca*+ concentrations over basal values. How- 
6h 12 h 
0.59 f 0.03 0.61 f 0.02 
0.25 f 0.01 0.50 f 0.04 
’ Cells (1 . lo6 cell/ml) were ~cultnred with or without 1 pg/ml LPS for indicated times. Cyclic AMP phosphodiesterase activity was measured as 
described in Section 2. The results are expressed as the means + S.D. of triplicate cultures. 
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Fig. 4. Effect of protein kinase inhibitor (H-89) on LPS-induced reduction 
of TK activity. J774 cell monolayers (1. lo6 cells) were pretreated with 
(broken lines) or without (solid lines) 1 pM H-89 for 1 h and thereafter 
cultured with the indicated doses of LPS (0.1 ng to 10 pg/ml) for 6 h 
(squares) or 12 h (circles). The TK activity in the control culture at 6 and 
12 h were 1.75 + 0.15 unit and 1.65 + 0.15 unit, respectively. Each value 
is expressed as the mean percentage f SD. of triplicate cultures and were 
settled as 100%. 
ever, ionomycin had no effect on the TK activity (data not 
shown). Therefore, Ca2+ mobilization is not apparently 
involved in the LPS-induced reduction of TK activity. 
3.7. Effect of indomethacin and pertussis toxin on TK 
activity 
When macrophages are treated with LPS, arachidonate 
is metabolized to PGE,, 6-oxoprostagrandin Fla, throm- 
boxane B2 and leukotriene C4 [24,25]. We investigated 
whether arachidonic acid metabolites are involved in LPS- 
induced reduction of TK activity. Pretreatment of J774 
cells with indomethacin (0.1 to 10 PM) had no effect on 
the LPS-induced reduction of TK activity (data not shown). 
Recently it was reported that some biological effects of 
LPS might be linked to the pertussis toxin-sensitive G 
protein [3,26]. However, pretreatment with 1 to 100 ng/ml 
pertussis toxin also failed to prevent LPS-induced reduc- 
tion of TK activity (data not shown). 
4. Discussion 
The findings in this study suggest that the reduction of 
the TK activity in 5774 cells after 6 h of LPS treatment is 
related to intracellular CAMP accumulation, which is 
caused by a decreased activity of the low K, CAMP 
phosphodiesterase, with subsequent increase in the activity 
of PK-A. 
Several reports have shown that some effects of LPS on 
macrophage cell lines are mediated via Gi protein [3,26- 
291. In the present study, however, pretreatment of 5774 
cells with pertussis toxin did not affect the suppressive 
effect of LPS on TK activity. It has also been reported that 
LPS or lipid A treatment enhances the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate and leads to an in- 
crease in intracellular Ca2+ concentration [19,27] and acti- 
vation of PK-C [19,20,27]. However, the increase in intra- 
cellular Ca2+ concentration observed in 5774 cells after 
ionomycin treatment could not affect the TK activity. 
Thus, Ca2+ mobilization was not involved in LPS-induced 
reduction of TK activity. In addition, TPA, a potent activa- 
tor of PK-C, had no effect on LPS-induced reduction of 
TK activity. 
From the data reported here, inhibition of CAMP phos- 
phodiesterase led to an elevation of the intracellular CAMP 
concentration and marked reduction of TK activity. PGE, 
can elevate intracellular CAMP concentration [30,31] and 
suppress the thymidine incorporation in monocyte/macro- 
phage cell series [6]. Since LPS stimulates macrophages to 
release PGE, copiously [32], there was the possibility that 
intracellular CAMP accumulation and reduction of TK 
activity by LPS might be induced through an autocrine 
effect of PGE, released from the 5774 cells. The following 
observations, however, suggest that LPS does not act 
indirectly via macrophage-derived mediators to suppress 
TK activity on J774 cells: (1) there was no reduction of 
TK activity or suppression of [ 3H]thymidine incorporation 
when PGE, was exogenously added in same amounts as 
those released by LPS-treated macrophages (0.2 nmol/ml) 
(data not shown); (2) cyclooxygenase inhibitors such as 
indomethacin had no effect on LPS-induced reduction of 
TK activity; and (3) intracellular CAMP accumulation in- 
duced by 5 PM PGE, occurs much more rapidly and 
prominently than that induced by LPS. 
Cyclic AMP accumulation by LPS was not due to an 
increase in adenylate cyclase activity but due to a decrease 
in the low K, CAMP phosphodiesterase activity. The 
gradual increase (during the first 6 h after LPS treatment) 
and decrease (from 6 to 12 h after LPS treatment) of 
intracellular CAMP levels corresponded with inverse 
changes of CAMP phosphodiesterase activity. The mecha- 
nism of decreased low K, CAMP phosphodiesterase activ- 
ity remains obscure, but does not seem to involve the 
induction of inhibitory factors in LPS-treated cells. It 
might be presumed that either a decrease in the enzyme 
protein synthesis or the induction of proteolytic enzymes 
by LPS treatment can reduce the CAMP phosphodiesterase 
activity. This would be compatible with the relative delay 
in CAMP accumulation (peak at 6 h) induced by LPS as 
compared to that induced by agents acting directly on 
adenylate cyclase or phosphodiesterase. 
LPS treatment increases tyrosine phosphorylation of 
several proteins in the RAW264.7 macrophage cell line 
and in resident peritoneal macrophages [33], and activation 
of a tyrosine kinase augments intracellular CAMP levels 
[34]. In our preliminary investigations, Herbimycin A, a 
potent and selective tyrosine kinase inhibitor, failed to 
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restore LPS-induced reduction of TK activity. However, 
addition of a potent and selective PK-A inhibitor (H-89) to 
the cell culture considerably reduced the suppressive effect 
of LPS on TK activity. At 6 h of LPS treatment H-89 
restored 63% of the suppression, but at 12 h it restored 
only 23%. Moreover, for periods up to 6 h of LPS 
treatment, time course of PK-A activity correlated with 
that of the reduced TK alctivity, but this correlation could 
not be observed after 12 h. These findings suggest that at 
an early stage (up to 6 h), LPS-induced reduction of TK 
activity mainly involves the elevation of intracellular CAMP 
levels followed by the increased activity of PK-A, but not 
at later stages (from 12 to 24 h). Therefore, we speculated 
that in 5774 cell line the intracellular CAMP accumulation 
probably is a trigger that sets on a signaling pathway 
leading to the more prolonged suppressive effect of LPS 
on TK activity. At the pre.sent time, we cannot pinpoint the 
nature of such mechanisms or whether their effect on TK 
activity is due to regulation at a transcriptional, transla- 
tional or posttranslational level. Recently, modulation of 
TK catalytic efficiency by differential phosphorylation dur- 
ing the cell cycling has been reported [35]. However, this 
phosphorylation was insensitive to H-7, and we have not 
observed suppression of TK activity by preincubation with 
purified PK-A and ATP. Thus, direct phosphorylation of 
TK by PK-A is an unlikely mechanism. Terminally differ- 
entiating cells appear to control TK activity mainly at a 
posttranscriptional level, and endogenous TK mRNA may 
be translationally repressed under various conditions of 
growth arrest [36]. To determine if a similar mechanism is 
involved in LPS-induced TK suppression, careful studies 
of the TK enzyme and mRNA expression following LPS 
exposure will be necessary. 
The biological role in the cell function of such TK 
activity suppression by e:levated intracellular CAMP con- 
centration is not clear. IElevation of intracellular CAMP 
concentration have been shown to be involved in the 
differentiation of a leukemic cell line [37], and elevations 
of intracellular CAMP concentration [38] and PK-A [39] 
have been shown to accompany differentiation of human 
monocytes in culture. Down-regulation of DNA synthesis 
occurs during differential:ion of many cells types [40,41]. 
We have observed that in macrophage activation, the 
suppression of [ 3 Hlthymidine incorporation and epithelioid 
granuloma formation are parallel events [8]. Since TK 
activity is responsible for the salvage of dUrd and dThd, it 
is possible that the decrease in incorporation of 
[3H]thymidine into DNA as measured in the present work 
does not represent a decrease in the DNA synthesis per se. 
However, we have previosusly described that the activity of 
DNA polymerase CX, altihough virtually unaltered at 6 h 
and 24 h, is markedly reduced after 48 h of LPS addition 
[9]. Therefore, the decrease in TK activity may be one of a 
sequence of events leading to a general suppression of 
DNA synthesis, inhibitio:n of cell proliferation and induc- 
tion of differentiation in ALPS-treated macrophages. 
The involvement of cyclic nucleotides in the regulation 
of macrophage activation, differentiation and proliferation 
has been studied in a number of laboratories [42,43]. 
However, despite several biological studies defining the 
complexities of CAMP-protein kinase pathway, it is not 
clear how these pathways regulate macrophage function. 
Recently several reports have indicated that in murine 
macrophages LPS-induced substrate proteins which were 
phosphorylated by serine/threonine kinases, and these 
phosphorylated proteins had a crucial role in macrophage 
activation [43-451. Based on the data from the present 
study, we can speculate that CAMP accumulation induced 
by LPS, resulting in the activation of PK-A, could sup- 
press TK activity through phosphorylation of target protein 
substrates in J774 cells. 
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